Waldenstrom's Macroglobulinemia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Zanubrutinib in Patients With Waldenstr öm's Macroglobulinemia (ARIADNE)
Condition: Waldenström's Macroglobulinemia Intervention: Drug: Zanubrutinib Sponsors: iOMEDICO AG; BeiGene Switzerland GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 13, 2022 Category: Research Source Type: clinical trials
